I continue to believe Docusign's shares are a strong buy due to their innovative AI-driven contract management system and expanding market opportunities in real estate and healthcare. The company's ...

DocuSign (DOCU) is back in focus after its shares hit a 52 week low, even as analysts keep reaffirming positive ratings and the company rolls out new AI powered eSignature features. See our latest ...

Docusign is an attractive growth stock, trading below intrinsic value, with strong profitability and cash flow despite aggressive expansion into contract lifecycle management. In Q1'26, DOCU achieved ...